Table 1 Characteristics of studies reporting adherence to ART in Cameroon
Reference | Year | City | Study design (sample size) | Adherence rate | Method | Cost of ART/month for that year in USD* |
|---|---|---|---|---|---|---|
Laurent et al. | 2000-2003 | Douala | Cross-sectional retrospective (788) | <50% μ | Scheduled visits attended | 128 |
Kouanfack et al. | 2002-2003 | Yaoundé | Prospective cohort (60) | 88.7%, (97.5%) | Biological markers, (Self Report) | 51.2 (free for participants) |
Mosoko et al. | 2002-2005 | Limbe | Cross-sectional retrospective α (2920) | 10.1% | Scheduled visits attended | 51.2 |
Boyer et al.[28] | 2006 | Yaoundé | Cross-sectional (532) | 56.6% | Self Report β | 12.8 |
Rougemont et al. | 2006 | Yaoundé | Prospective cohort (312) | 64% (78%) | Pharmacy data (Self report) | 12.8 |
Boyer et al.[32] | 2006-2007 | Multiple locations | Cross-sectional (3151) | 53.9% | Self report β | 12.8 |
Roux et al. | 2006-2008 | Yaoundé | Prospective cohort (401) | 61-73% | Self report β | 12.8 |
Mahy et al. | 2007-2008 | Tokombere | Cross-sectional (56) | 95% (80%) | self report β (Pharmacy data) | 0 |
Mbopi-Keou et al. | 2010 | Dschang | Cross-sectional (356) | 80.2% (48.7) | Self report β (Pharmacy data) | 0 |
CAMPS | 2010 | Yaoundé | Cross-sectional (200) | 90.5% | Self report β | 0 |